Louis B Nabors

Louis B Nabors

University of Alabama Birmingham - Birmingham / United States
Others
AD Scientific Index ID: 1702289
University of Alabama at Birmingham
person_outline Louis B Nabors's MOST POPULAR ARTICLES
1-) Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre …R Stupp, ME Hegi, T Gorlia, SC Erridge, J Perry, YK Hong, KD Aldape, ...The lancet oncology 15 (10), 1100-1108, 20148732014
2-) Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trialM Weller, N Butowski, DD Tran, LD Recht, M Lim, H Hirte, L Ashby, ...The Lancet Oncology 18 (10), 1373-1385, 20178682017
3-) Human cytomegalovirus infection and expression in human malignant gliomaCS Cobbs, L Harkins, M Samanta, GY Gillespie, S Bharara, PH King, ...Cancer research 62 (12), 3347-3350, 20028572002
4-) Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastomaTT Batchelor, P Mulholland, B Neyns, LB Nabors, M Campone, A Wick, ...Journal of Clinical Oncology 31 (26), 3212-3218, 20136242013
5-) Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiformeDA Reardon, KL Fink, T Mikkelsen, TF Cloughesy, A O\'Neill, S Plotkin, ...Journal of clinical oncology 26 (34), 5610-5617, 20085812008